We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000725:SZSEHyundai Engineering & Construction Co.,Ltd. Analysis

Data as of 2026-06-01 - not real-time

CN¥5.36

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

BOE Technology is trading at CNY 5.36, comfortably above its 20‑day (CNY 4.66), 50‑day (CNY 4.29) and 200‑day (CNY 4.20) simple moving averages, indicating a strong bullish bias. The RSI sits at 65.4 and the MACD line is positive (0.35) with a bullish histogram, while volume is on an increasing trend, all of which support short‑term upside potential. Valuation appears reasonable: the trailing PE of 31.5 is well below the industry average PE of 42.7, and the price‑to‑sales ratio is under 1 (0.97), suggesting the stock is not overly expensive relative to peers. The beta of 0.31 points to low market‑wide volatility, and the Fear‑Greed Index at 93 (Extreme Greed) reflects strong investor sentiment.
Fundamentally, the company faces challenges: revenue growth is modest at 0.8 %, margins are thin (gross 13.7 %, operating 5.5 %, profit 2.9 %), and the debt‑to‑equity ratio is high at 68.9 %, though cash balances are substantial. Return metrics are weak (ROE 2.3 %, ROA 0.7 %) and free cash flow is limited (CNY 0.85 bn). The dividend yield of 0.98 % with a payout ratio of 29 % appears sustainable, providing a modest income cushion for investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI indicating momentum
  • Price above all major SMAs supporting trend
  • Increasing trading volume confirming participation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation near fair value with modest upside
  • High debt-to-equity ratio limiting financial flexibility
  • Limited earnings growth and thin profit margins

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Low ROE and ROA suggest weak long‑term profitability
  • Diversified product portfolio (IoT, MLED, smart medicine) provides strategic upside
  • Sustainable dividend offering a defensive income component

Key Metrics & Analysis

Financial Health

Revenue Growth0.80%
Profit Margin2.90%
P/E Ratio31.5
ROE2.30%
ROA0.71%
Debt/Equity68.95
P/B Ratio1.5
Op. Cash FlowCN¥47.4B
Free Cash FlowCN¥852.2M
Industry P/E42.7

Technical Analysis

TrendBullish
RSI65.4
SupportCN¥4.08
ResistanceCN¥6.09
MA 20CN¥4.66
MA 50CN¥4.29
MA 200CN¥4.20
MACDBullish
VolumeIncreasing
Fear & Greed Index93.04

Valuation

Target PriceCN¥4.92
Upside/Downside-8.25%
GradeFair
TypeBlend
Dividend Yield0.98%

Risk Assessment

Beta0.31
Volatility61.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.